Two distinguished scientists from UMass Medical School—Michael Green, MD, PhD, and Allan Jacobson, PhD—have been elected to the American Academy of Arts and Sciences Class of 2018. They join a group of 213 individuals elected this year that includes Barack Obama and 2018 UMMS Commencement speaker Huda Y. Zoghbi, MD.
Renowned pediatrician and cancer researcher Patricia Donahoe, MD, is the recipient of the 2018 Gregory Pincus Medal from UMass Medical School. She delivered the Pincus Memorial Lecture at UMMS on April 11.
As senior director of clinical affairs at MassBiologics of UMass Medical School, Heidi Smith, MD, PhD, is focused on developing products that address unmet medical needs and diseases of public health concern. Learn more in this Women in Science video.
Renowned pediatrician and cancer researcher Patricia Donahoe, MD, has been named the 2018 recipient of the Gregory Pincus Medal by UMass Medical School. She will deliver the Pincus Memorial Lecture at UMMS on April 11.
Inflammatory bowel disease patients are taking part in a pilot clinical trial underway at UMass Medical School to examine how diet may relieve symptoms. Researchers are seeking to better understand how the anti-inflammatory diet works by altering the bacteria which populate the intestinal microbiome.
Chancellor Michael F. Collins and several members of the UMass Medical School faculty joined former Secretary of State John F. Kerry for the 2018 Shenzhen Life and Health Sciences Conference in Shenzhen, China.
A Phase I clinical trial testing the safety of vaccines that might have the potential to prevent HIV infection will begin this month at four sites in the United States, marking the latest step in a three-decade quest by UMass Medical School’s Shan Lu, MD, PhD, to harness the power of DNA vaccines.
An international team of researchers co-led by John Landers, PhD, has identified KIF5A as a new gene associated with the development of amyotrophic lateral sclerosis. The discovery, published in the journal Neuron, advances the understanding of what causes ALS and further implicates the role of cytoskeletal defects in the axon as a common factor in the disease.
UMass Medical School researchers have identified a re-emergence in fungal infections associated with cases of illicit intravenous drug use in Massachusetts as opioid overdoses continue to soar, according to Stuart Levitz, MD.
The annual U.S. News & World Report rankings of the best graduate schools names UMass Medical School in the top 10 percent nationwide in primary care, coming in 14th among 144 medical schools and 33 schools of osteopathic medicine surveyed by the weekly news magazine in its 2019 edition of the “Best Graduate Schools.”